CALL US: 210-949-0122
Studies for Seniors »

By: Clinical Trials of Texas, Inc.

Ebola is continuing to make headlines this week, but physicians say that elderly adults should also be aware of other illnesses that pose health risks like RSV and the flu.

“Respiratory Syncytial Virus (RSV) is something to watch out for especially for adults 60 and over,” says Dr. Douglas Denham of Clinical Trials of Texas. “Although the virus does not pose a serious threat to healthy, younger adults, it can be serious for the elderly and those with compromised immune systems.”

RSV season typically hits in mid-October and lasts through January, following closely along with flu season.

Denham said that symptoms of RSV often mimic that of the flu and include coughing, fever, loss of appetite, headaches and difficulty breathing.

In some circumstances, RSV can lead to pneumonia, bronchitis and possible death.

“The best way to avoid the flu and potentially RSV, is to get your annual vaccinations,” says Denham.
Denham says that although there is currently no approved vaccine for RSV, his clinic is enrolling subjects 60 and over to participate in an investigational RSV vaccine.

“The great thing about this new study is that all subjects receive the flu vaccine at no charge if they haven’t already gotten it,” said Denham.

For more information on participating in the RSV research study at CTT, call 210.949.0122 or visit their website at SAresearch.com.

About Clinical Trials of Texas

Clinical Trials of Texas (CTT) is one of the leading clinical research organizations in the country. With over 50 board certified physicians, and new Phase I facility, CTT conducts studies in a multitude of therapeutic areas, phases and design types. Working with major pharmaceutical and device sponsors, CRO’s, as well as smaller bio-tech companies, CTT successfully and safely continues to lead the way in advanced clinical research. To learn more or to participate in a research study, visit SAresearch.com.